Assegnare 0 punti se tutte le sottrazioni vengono sbagliate assegnare 1 punto se solo 1 sottrazione corretta, 2 punti per 2 o 3 sottrazioni corrette 3 punti se il partecipante esegue correttamente 4 o 5 sottrazioni. Anvifen effectiveness is considered from the point of view of the participation of GABAergic structures in the pathogenesis of the phenomenon under study. Punteggio - In questa prova si assegnano al massimo 3 punti. RESULTS: Results before/after treatment: HADS anxiety 10.5 /7 (p=0.000025) HADS depression 5 / 4 (p=0.00003) MoCA 22 / 25 (p=0.00001) TMT-B 281 sec / 231 sec (p=0.00001) FAS 27 / 20 (p=0.00001) questionnaire for scoring the subjective characteristics of sleep 15 / 25 (p=0.00001) SF-36 Physical Health 43.8 / 53.8 (p=0.00001) SF-36 Mental Health 34 / 47 (p=0.00001).ĬONCLUSION: The authors conclude that anxiety disorder and asthenia play an important role in the pathogenesis of post-COVID brain fog syndrome. According to the indicated scales, no statistically significant differences were found between the groups, therefore, the data of all patients were combined into one group, the indicators were compared before and after treatment (Anvifen 500 mg three times a day for 21 days). End here point to (E). Begin here point to (1) and draw a line from 1 then to A then to 2 and so on. Assessment scales: Hospital Anxiety and Depression Scale (HADS), Montreal Cognitive Assessment Scale (MoCA) Trail Making Test part B (TMT-B) a scoring questionnaire for the subjective characteristics of sleep Fatigue Assessment Scale (FAS), 36-Item Short Form Survey (SF-36). Administration: The examiner instructs the subject: 'Please draw a line going from a number to a letter in ascending order. Group 1 (n=40 43.4±4.5 years) were treated at home group 2 (n=32 44.9±5.5 years) were treated in a hospital without oxygen support group 3 (n=20 45.1±4.8 years) were treated in a hospital with oxygen support. MATERIAL AND METHODS: 92 post-COVID-19 patients with no organic brain damage who complain of brain fog 12 weeks after the onset of COVID-19 symptoms.
Il tempo di somministrazione del MoCa è di 10 minuti. Valuta diversi domini cognitivi: attenzione e concentrazione, funzioni esecutive, memoria, linguaggio, abilità visuocostruttive, astrazione, calcolo e orientamento. The scores from each section are added up to get the total MoCA score, which ranges from 0 to 30. A combined score has stronger incremental validity than the individual index scores.OBJECTIVE: To determine the significance of anxiety disorder and comorbid disorders in patients with post-covid brain fog, to determine the effectiveness of the GABAergic nootropic drug with an anxiolytic effect - Anvifen. Il Montreal Cognitive Assessment (MoCA) è stato progettato come strumento per un rapido screening del deterioramento cognitivo lieve. The MoCA test is scored by assigning points to different sections and tasks within the test. Do eského prostedí ho uvedl v roce 2006 J. Ziad Nasreddine, a následn jej v roce 2005 publikoval (Nasreddineet al., 2005) 1. Conclusion: Administration of the entire MoCA is more informative than the index scores, especially in distinguishing normal cognition versus MCI. Montrealský kognitivní test (Montreal Cognitive Assessment - MoCA, také Nasreddinv test) vyvinul v roce 1996 kanadský specialista na kognitivní poruchy a Alzheimerovu chorobu Dr. A combined score incorporating the Memory, Executive, and Orientation indexes also improved incremental validity for all 3 group comparisons. Results: Effect sizes for the total score were large ( 0.80) and exceeded the index scores in differentiating those with MCI versus normal cognition, MCI versus AD, and AD versus normal cognition. Methods: Effect sizes were calculated for Alzheimer's Disease Neuroimaging Initiative research participants with normal cognition (n = 295), MCI (n = 471), or AD (n = 150). Abstract : Background/Aims: The aim of this paper was to evaluate the incremental validity of the Montreal Cognitive Assessment (MoCA) index scores and the MoCA total score in differentiating individuals with normal cognition versus mild cognitive impairment (MCI) or Alzheimer disease (AD).